By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Selexis SA And IAVI Expand Collaboration To Advance Multiple HIV Vaccine Candidates Toward Clinical Testing 9/22/2016 11:12:16 AM
Selexis SA And International AIDS Vaccine Initiative Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing 9/22/2016 11:11:55 AM
Selexis SA Enters Into Commercial Cell Line License Agreement With Pieris For Immuno-Oncology Bispecific Drug Candidate 9/7/2016 11:31:18 AM
ASLAN Pharmaceuticals Pte Ltd Enters Service Agreement With Selexis SA For Development Of A Proprietary Cell Line For Expression Of ASLAN004 7/27/2016 10:50:53 AM
Symphogen Advances Sym015 Into Clinical Development Using Selexis SA SGEs (Selexis Genetic Elements) 6/29/2016 9:00:11 AM
Progenics (PGNX) Signs Commercial License Agreement With Selexis SA For Use Of Proprietary Cell Line And Suretechnology Platform 6/21/2016 10:13:08 AM
Liomont Signs Commercial License Agreement With Selexis SA For Use Of Proprietary Cell Line And Suretechnology Platform 6/2/2016 9:51:12 AM
Selexis SA Announces Spring 2016 Conference Schedule 3/31/2016 11:46:27 AM
Selexis SA Announces Spring 2016 Conference Schedule 3/31/2016 9:53:46 AM
Complix NV Advances Novel Biospecific Immunotherapeutic CMX-02 - Enters Agreement With Selexis SA To Access SUREtechnology Platform 12/14/2015 8:50:22 AM
12345
//-->